Verification evidence is still being completed.
PDF / print export
Asper Biogene
Tartu, Estonia
- Verified lead
- Hardi Tamm
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Genetic Testing, NGS Services, and Clinical Diagnostic Panels
- Review cycle
- May 2026
- Full address
- Vaksali 17a, 50410 Tartu, Estonia
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Asper Biogene management-team page confirming the current executive lead in Tartu.
- Editorial note
- Asper Biogene adds an Estonia genomics node with a source-backed CEO, a fixed Tartu diagnostic site, and official ISO 15189 / Health Board disclosures tied to the laboratory operation.
Genetic Testing, NGS Services, and Clinical Diagnostic Panels
ISO 15189:2012 #M014, ISO 9001:2015 #EST04518A, Health Board licence #L01469
Asper Biogene adds an Estonia genomics node with a source-backed CEO, a fixed Tartu diagnostic site, and official ISO 15189 / Health Board disclosures tied to the laboratory operation.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Asper Biogene adds an Estonia genomics node with a source-backed CEO, a fixed Tartu diagnostic site, and official ISO 15189 / Health Board disclosures tied to the laboratory operation.
- Lead
- Hardi Tamm (verified ↗)
- Address
- Vaksali 17a, 50410 Tartu, Estonia (source ↗)
- Compliance
- ISO 15189:2012 #M014 · ISO 9001:2015 #EST04518A
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Clinical genetic testing and sequencing services
- Capabilities
- Disease-Specific DNA Panels · Whole Exome and Genome Testing · Clinical Genetic Diagnostics
- Founded
- 1999
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Hardi Tamm
Chief Executive Officer
Full addressVaksali 17a, 50410 Tartu, Estonia
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official Asper Biogene contacts page listing the Vaksali 17a Tartu diagnostic site.
Open sourceClinical genetic testing and sequencing services
Tartu, Estonia. Genetic Testing, NGS Services, and Clinical Diagnostic Panels. Review completed on 21 Mar 2026.
Estonian Health Board and ISO-accredited laboratory oversight
ISO 15189:2012 #M014, ISO 9001:2015 #EST04518A, Health Board licence #L01469
Genetic Testing, NGS Services, and Clinical Diagnostic Panels
Asper Biogene adds an Estonia genomics node with a source-backed CEO, a fixed Tartu diagnostic site, and official ISO 15189 / Health Board disclosures tied to the laboratory operation.
Editorial note
Asper Biogene adds an Estonia genomics node with a source-backed CEO, a fixed Tartu diagnostic site, and official ISO 15189 / Health Board disclosures tied to the laboratory operation.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Disease-Specific DNA Panels
Whole Exome and Genome Testing
Clinical Genetic Diagnostics
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Genetic testing laboratory
NGS diagnostic workflow
Clinical sample and reporting systems
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Asper Biogene located?
- Asper Biogene operates from Vaksali 17a, 50410 Tartu, Estonia, Tartu, Estonia.
- Who runs Asper Biogene?
- Asper Biogene is led by Hardi Tamm, Chief Executive Officer. Verified 21 Mar 2026.
- What certifications does Asper Biogene hold?
- Asper Biogene is documented under ISO 15189:2012 #M014, ISO 9001:2015 #EST04518A.
- What does Asper Biogene do?
- Asper Biogene adds an Estonia genomics node with a source-backed CEO, a fixed Tartu diagnostic site, and official ISO 15189 / Health Board disclosures tied to the laboratory operation. Core capabilities: Disease-Specific DNA Panels, Whole Exome and Genome Testing, Clinical Genetic Diagnostics.
Editorial context
Related technical briefs
Briefs that name Tartu as a covered market or city.